Table 1 Characteristics of included studies in this meta-analysis.

No	First Author	Year	Population	Typing method	Diagnostic criteria	Patients	Controls	Molecular or serological study
1	Qin¹⁹	2015	Chinese	PCR-SSP	ND	100	100	Molecular
2	Papadopoulou¹⁵	2012	Swedish	PCR-SSP	WHO criteria, 1999	452	168	Molecular
3	Papadopoulou²¹	2009	Swedish	PCR-SSP	OGTT*	764	1191	Molecular
4	Wang²⁷	2008	Chinese	PCR-SSP	OGTT**	39	42	Molecular
5	Zhou²⁸	2007	Chinese	PCR-SSP	OGTT**	26	42	Molecular
6	Liu¹⁶	2006	Chinese	PCR-SSP	OGTT**	50	50	Molecular
7	Li²⁹	2005	Chinese	PCR-SSP	OGTT**	116	73	Molecular
8	Zhao¹⁸	2005	Chinese	PCR-SSP	WHO criteria, 1998	48	48	Molecular
9	Shaat²²	2004	Scandinavian and Arabian	Hybridisation	OGTT*	500	550	Molecular
10	Song²³	2002	Chinese	PCR-SSP	NDDG criteria	30	40	Molecular
11	Weng¹¹	2002	Swedish	Dot-blotting	OGTT*	65	86	Molecular
12	Ferber²⁴	1999	German	PCR-SSO	GDA criteria	184	254	Molecular
13	Vambergue²⁵	1997	French	AFLP	Carpenter and Coustan’s criteria	95	95	Molecular
14	Acton¹³	1997	African-American	Microdroplet cytoxicity procedure and/or PCR-SSP	NDDG criteria	465	232	Molecular
15	Lapolla¹⁷	1996	Italian	Microlymphocytotoxicity method	Carpenter and Coustan’s criteria	52	51	Serological
16	Rubinstein²⁶	1981	Puerto Rican and American	TCF	ND	136	417	Serological

PCR polymerase chain reaction, SSP sequence-specific primers, SSO sequence-specific oligonucleotide, AFLP Amplification Length Fragment Polymorphism, TCF two-color fluorescence, OGTT* based on 75-g OGTT and defined as a 2-h capillary glucose concentration (CGC) of at least 9 mmol/L, OGTT** based on 75-g OGTT and met at least two following conditions (0-h CGC ≥ 5.6 mmol/L; 1-h CGC ≥ 10.3 mmol/L; 2-h CGC ≥ 8.6 mmol/L; 3-h CGC ≥ 6.7 mmol/L), NDDG The national diabetes Data Group, GDA German Diabetes Association, ND not available data.

Quick links

Search